0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Embolization Particle Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-961
Home | Market Reports | Health | Pharmacy
Global Embolization Particle Market Insights Forecast to 2025

Global Embolization Particle Market Insights, Forecast to 2025

Code: QYRE-Auto-961
Report
May 2019
117 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.
In the industry, Sirtex Medical profits most in 2016 and recent years, while Merit Medical and BTG Medical ranked 2 and 3.The market share of them is 23.11%, 17.44% and 14.53% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are four mainly types of Embolization Particle, including Microspheres, Particles, DEBs and Radio-Embolic Microspheres. And Microspheres is the main type for Embolization Particle, and the Microspheres reached a sales value of approximately 347.54 M USD in 2016, with 34.55% of global sales volume.
The global Embolization Particle market is valued at 1170 million US$ in 2018 and will reach 3240 million US$ by the end of 2025, growing at a CAGR of 13.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Embolization Particle market based on company, product type, end user and key regions.

This report studies the global market size of Embolization Particle in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Embolization Particle in these regions.
This research report categorizes the global Embolization Particle market by top players/brands, region, type and end user. This report also studies the global Embolization Particle market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Sirtex Medical
    Merit Medical
    Cook Medical
    BTG Medical
    Boston Scientific Corporation
    Terumo Corporation
    HENGRUI Medical
    INterface BIOmaterials B.V.
    Alicon

Market size by Product
    Microspheres
    Particles (e.g. PVA Particles, Gelfoam Particles)
    Drug-eluting Beads (DEBs)
    Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Market size by End User
    Uterine Fibroid Embolization
    Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Liver Tumor Embolization
    Trauma Embolization
    Other

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Embolization Particle market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Embolization Particle market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Embolization Particle companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Embolization Particle submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Embolization Particle are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Embolization Particle market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Embolization Particle Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Embolization Particle Market Size Growth Rate by Product
        1.4.2 Microspheres
        1.4.3 Particles (e.g. PVA Particles, Gelfoam Particles)
        1.4.4 Drug-eluting Beads (DEBs)
        1.4.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
    1.5 Market by End User
        1.5.1 Global Embolization Particle Market Size Growth Rate by End User
        1.5.2 Uterine Fibroid Embolization
        1.5.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
        1.5.4 Liver Tumor Embolization
        1.5.5 Trauma Embolization
        1.5.6 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Embolization Particle Market Size
        2.1.1 Global Embolization Particle Revenue 2014-2025
        2.1.2 Global Embolization Particle Sales 2014-2025
    2.2 Embolization Particle Growth Rate by Regions
        2.2.1 Global Embolization Particle Sales by Regions
        2.2.2 Global Embolization Particle Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Embolization Particle Sales by Manufacturers
        3.1.1 Embolization Particle Sales by Manufacturers
        3.1.2 Embolization Particle Sales Market Share by Manufacturers
        3.1.3 Global Embolization Particle Market Concentration Ratio (CR5 and HHI)
    3.2 Embolization Particle Revenue by Manufacturers
        3.2.1 Embolization Particle Revenue by Manufacturers (2014-2019)
        3.2.2 Embolization Particle Revenue Share by Manufacturers (2014-2019)
    3.3 Embolization Particle Price by Manufacturers
    3.4 Embolization Particle Manufacturing Base Distribution, Product Types
        3.4.1 Embolization Particle Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Embolization Particle Product Type
        3.4.3 Date of International Manufacturers Enter into Embolization Particle Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Embolization Particle Sales by Product
    4.2 Global Embolization Particle Revenue by Product
    4.3 Embolization Particle Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Embolization Particle Breakdown Data by End User

6 North America
    6.1 North America Embolization Particle by Countries
        6.1.1 North America Embolization Particle Sales by Countries
        6.1.2 North America Embolization Particle Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Embolization Particle by Product
    6.3 North America Embolization Particle by End User

7 Europe
    7.1 Europe Embolization Particle by Countries
        7.1.1 Europe Embolization Particle Sales by Countries
        7.1.2 Europe Embolization Particle Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Embolization Particle by Product
    7.3 Europe Embolization Particle by End User

8 Asia Pacific
    8.1 Asia Pacific Embolization Particle by Countries
        8.1.1 Asia Pacific Embolization Particle Sales by Countries
        8.1.2 Asia Pacific Embolization Particle Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Embolization Particle by Product
    8.3 Asia Pacific Embolization Particle by End User

9 Central & South America
    9.1 Central & South America Embolization Particle by Countries
        9.1.1 Central & South America Embolization Particle Sales by Countries
        9.1.2 Central & South America Embolization Particle Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Embolization Particle by Product
    9.3 Central & South America Embolization Particle by End User

10 Middle East and Africa
    10.1 Middle East and Africa Embolization Particle by Countries
        10.1.1 Middle East and Africa Embolization Particle Sales by Countries
        10.1.2 Middle East and Africa Embolization Particle Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Embolization Particle by Product
    10.3 Middle East and Africa Embolization Particle by End User

11 Company Profiles
    11.1 Sirtex Medical
        11.1.1 Sirtex Medical Company Details
        11.1.2 Company Business Overview
        11.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Sirtex Medical Embolization Particle Products Offered
        11.1.5 Sirtex Medical Recent Development
    11.2 Merit Medical
        11.2.1 Merit Medical Company Details
        11.2.2 Company Business Overview
        11.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Merit Medical Embolization Particle Products Offered
        11.2.5 Merit Medical Recent Development
    11.3 Cook Medical
        11.3.1 Cook Medical Company Details
        11.3.2 Company Business Overview
        11.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Cook Medical Embolization Particle Products Offered
        11.3.5 Cook Medical Recent Development
    11.4 BTG Medical
        11.4.1 BTG Medical Company Details
        11.4.2 Company Business Overview
        11.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 BTG Medical Embolization Particle Products Offered
        11.4.5 BTG Medical Recent Development
    11.5 Boston Scientific Corporation
        11.5.1 Boston Scientific Corporation Company Details
        11.5.2 Company Business Overview
        11.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Boston Scientific Corporation Embolization Particle Products Offered
        11.5.5 Boston Scientific Corporation Recent Development
    11.6 Terumo Corporation
        11.6.1 Terumo Corporation Company Details
        11.6.2 Company Business Overview
        11.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Terumo Corporation Embolization Particle Products Offered
        11.6.5 Terumo Corporation Recent Development
    11.7 HENGRUI Medical
        11.7.1 HENGRUI Medical Company Details
        11.7.2 Company Business Overview
        11.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 HENGRUI Medical Embolization Particle Products Offered
        11.7.5 HENGRUI Medical Recent Development
    11.8 INterface BIOmaterials B.V.
        11.8.1 INterface BIOmaterials B.V. Company Details
        11.8.2 Company Business Overview
        11.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 INterface BIOmaterials B.V. Embolization Particle Products Offered
        11.8.5 INterface BIOmaterials B.V. Recent Development
    11.9 Alicon
        11.9.1 Alicon Company Details
        11.9.2 Company Business Overview
        11.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Alicon Embolization Particle Products Offered
        11.9.5 Alicon Recent Development

12 Future Forecast
    12.1 Embolization Particle Market Forecast by Regions
        12.1.1 Global Embolization Particle Sales Forecast by Regions 2019-2025
        12.1.2 Global Embolization Particle Revenue Forecast by Regions 2019-2025
    12.2 Embolization Particle Market Forecast by Product
        12.2.1 Global Embolization Particle Sales Forecast by Product 2019-2025
        12.2.2 Global Embolization Particle Revenue Forecast by Product 2019-2025
    12.3 Embolization Particle Market Forecast by End User
    12.4 North America Embolization Particle Forecast
    12.5 Europe Embolization Particle Forecast
    12.6 Asia Pacific Embolization Particle Forecast
    12.7 Central & South America Embolization Particle Forecast
    12.8 Middle East and Africa Embolization Particle Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Embolization Particle Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Embolization Particle Product Picture
    Table Embolization Particle Market Segments
    Table Key Manufacturers Embolization Particle Covered
    Table Global Embolization Particle Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Embolization Particle Sales Market Share by Product 2014-2025
    Figure Microspheres Product Picture
    Table Major Manufacturers of Microspheres
    Figure Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
    Table Major Manufacturers of Particles (e.g. PVA Particles, Gelfoam Particles)
    Figure Drug-eluting Beads (DEBs) Product Picture
    Table Major Manufacturers of Drug-eluting Beads (DEBs)
    Figure Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
    Table Major Manufacturers of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
    Table Global Embolization Particle Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Uterine Fibroid Embolization
    Figure Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Figure Liver Tumor Embolization
    Figure Trauma Embolization
    Figure Other
    Figure Embolization Particle Report Years Considered
    Figure Global Embolization Particle Market Size 2014-2025 (Million US$)
    Figure Global Embolization Particle Sales 2014-2025 (K Units)
    Table Global Embolization Particle Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Embolization Particle Sales by Regions 2014-2019 (K Units)
    Table Global Embolization Particle Sales Market Share by Regions 2014-2019
    Figure Global Embolization Particle Sales Market Share by Regions 2014-2019
    Figure 2018 Global Embolization Particle Sales Market Share by Regions
    Table Global Embolization Particle Revenue by Regions 2014-2019 (Million US$)
    Table Global Embolization Particle Revenue Market Share by Regions 2014-2019
    Figure Global Embolization Particle Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Embolization Particle Revenue Market Share by Regions
    Table Global Embolization Particle Sales by Manufacturers (2014-2019) (K Units)
    Table Global Embolization Particle Sales Share by Manufacturers (2014-2019)
    Figure Global Embolization Particle Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Embolization Particle Revenue by Manufacturers (2014-2019) (Million USD)
    Table Embolization Particle Revenue Share by Manufacturers (2014-2019)
    Figure Embolization Particle Value Share by Manufacturers in 2018
    Table Key Manufacturers Embolization Particle Price (2014-2019) (USD/Unit)
    Table Embolization Particle Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Embolization Particle Product Type
    Table Date of International Manufacturers Enter into Embolization Particle Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Embolization Particle Sales by Product (2014-2019) (K Units)
    Table Global Embolization Particle Sales Share by Product (2014-2019)
    Figure Global Embolization Particle Sales Market Share by Product (2014-2019)
    Figure Global Embolization Particle Sales Market Share by Product in 2018
    Table Global Embolization Particle Revenue by Product (2014-2019) (Million US$)
    Table Global Embolization Particle Revenue Share by Product (2014-2019)
    Figure Global Embolization Particle Revenue Market Share by Product (2014-2019)
    Figure Global Embolization Particle Revenue Market Share by Product in 2018
    Table Embolization Particle Price by Product 2014-2019 (USD/Unit)
    Table Global Embolization Particle Sales by End User (2014-2019) (K Units)
    Table Global Embolization Particle Sales Share by End User (2014-2019)
    Figure Global Sales Embolization Particle Market Share by End User (2014-2019)
    Figure Global Sales Embolization Particle Market Share by End User in 2018
    Figure North America Embolization Particle Sales Growth Rate 2014-2019 (K Units)
    Figure North America Embolization Particle Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Embolization Particle Sales by Countries (2014-2019) (K Units)
    Table North America Embolization Particle Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Embolization Particle Sales Market Share by Countries
    Table North America Embolization Particle Revenue by Countries (2014-2019) (Million US$)
    Table North America Embolization Particle Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Embolization Particle Revenue Market Share by Countries
    Figure United States Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure United States Embolization Particle Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Embolization Particle Sales by Product (2014-2019) (K Units)
    Table North America Embolization Particle Sales Market Share by Product (2014-2019)
    Figure 2018 North America Embolization Particle Market Share by Product
    Table North America Embolization Particle Sales by End User (2014-2019) (K Units)
    Table North America Embolization Particle Sales Market Share by End User (2014-2019)
    Figure 2018 North America Embolization Particle Market Share by End User
    Figure Europe Embolization Particle Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Embolization Particle Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Embolization Particle Sales by Countries (2014-2019) (K Units)
    Table Europe Embolization Particle Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Embolization Particle Sales Market Share by Countries
    Table Europe Embolization Particle Revenue by Countries (2014-2019) (Million US$)
    Table Europe Embolization Particle Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Embolization Particle Revenue Market Share by Countries
    Figure Germany Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure France Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure UK Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Embolization Particle Sales by Product (2014-2019) (K Units)
    Table Europe Embolization Particle Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Embolization Particle Market Share by Product
    Table Europe Embolization Particle Sales by End User (2014-2019) (K Units)
    Table Europe Embolization Particle Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Embolization Particle Market Share by End User
    Figure Asia Pacific Embolization Particle Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Embolization Particle Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Embolization Particle Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Embolization Particle Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Embolization Particle Sales Market Share by Countries
    Table Asia Pacific Embolization Particle Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Embolization Particle Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Embolization Particle Revenue Market Share by Countries
    Figure China Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure China Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure India Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Embolization Particle Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Embolization Particle Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Embolization Particle Market Share by Product
    Table Asia Pacific Embolization Particle Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Embolization Particle Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Embolization Particle Market Share by End User
    Figure Central & South America Embolization Particle Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Embolization Particle Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Embolization Particle Sales by Countries (2014-2019) (K Units)
    Table Central & South America Embolization Particle Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Embolization Particle Sales Market Share by Countries
    Table Central & South America Embolization Particle Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Embolization Particle Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Embolization Particle Revenue Market Share by Countries
    Figure Brazil Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Embolization Particle Sales by Product (2014-2019) (K Units)
    Table Central & South America Embolization Particle Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Embolization Particle Market Share by Product
    Table Central & South America Embolization Particle Sales by End User (2014-2019) (K Units)
    Table Central & South America Embolization Particle Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Embolization Particle Market Share by End User
    Figure Middle East and Africa Embolization Particle Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Embolization Particle Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Embolization Particle Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Embolization Particle Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Embolization Particle Sales Market Share by Countries
    Table Middle East and Africa Embolization Particle Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Embolization Particle Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Embolization Particle Revenue Market Share by Countries
    Figure GCC Countries Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Embolization Particle Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Embolization Particle Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Embolization Particle Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Embolization Particle Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Embolization Particle Market Share by Product
    Table Middle East and Africa Embolization Particle Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Embolization Particle Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Embolization Particle Market Share by End User
    Table Sirtex Medical Company Details
    Table Sirtex Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Sirtex Medical Recent Development
    Table Merit Medical Company Details
    Table Merit Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merit Medical Recent Development
    Table Cook Medical Company Details
    Table Cook Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Cook Medical Recent Development
    Table BTG Medical Company Details
    Table BTG Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table BTG Medical Recent Development
    Table Boston Scientific Corporation Company Details
    Table Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Boston Scientific Corporation Recent Development
    Table Terumo Corporation Company Details
    Table Terumo Corporation Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Terumo Corporation Recent Development
    Table HENGRUI Medical Company Details
    Table HENGRUI Medical Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table HENGRUI Medical Recent Development
    Table INterface BIOmaterials B.V. Company Details
    Table INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table INterface BIOmaterials B.V. Recent Development
    Table Alicon Company Details
    Table Alicon Embolization Particle Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Alicon Recent Development
    Table Global Embolization Particle Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Embolization Particle Sales Market Share Forecast by Regions 2019-2025
    Table Global Embolization Particle Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Embolization Particle Revenue Market Share Forecast by Regions 2019-2025
    Table Global Embolization Particle Sales Forecast by Product 2019-2025 (K Units)
    Table Global Embolization Particle Sales Market Share Forecast by Product 2019-2025
    Table Global Embolization Particle Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Embolization Particle Revenue Market Share Forecast by Product 2019-2025
    Table Global Embolization Particle Sales Forecast by End User 2019-2025 (K Units)
    Table Global Embolization Particle Sales Market Share Forecast by End User 2019-2025
    Figure North America Embolization Particle Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Embolization Particle Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Embolization Particle Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Embolization Particle Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Embolization Particle Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Embolization Particle Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Embolization Particle Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Embolization Particle Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Embolization Particle Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Embolization Particle Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Embolization Particle Value Chain
    Table Embolization Particle Customers List
    Table Embolization Particle Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Divalproex Sodium Market Insights and Forecast to 2028
Global Divalproex Sodium Market Insights and Forecast to 2028

This medicine is an anticonvulsant that works in the brain tissue to stop seizures.Divalproex Sodium is also used to treat the manic phase of bipolar disorder manicdepressive illness and helps prevent migraine headaches.This medicine is available only with your doctors prescription.Market Analysis and Insights Global Divalproex Sodium MarketDue to the COVID19 pandemic the global Divalproex Sodium market size is estimated to be worth US 2335.7 million in 2022 and is forecast to a readjusted size of US 3350.9 million by 2028 with a CAGR of 6.2 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-13K9340
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global First Aid Kits Market Insights and Forecast to 2028
Global First Aid Kits Market Insights and Forecast to 2028

There is a wide variation in the contents of first aid kits based on the knowledge and experience of those putting it together the differing first aid requirements of the area where it may be used and variations in legislation or regulation in a given area.Market Analysis and Insights Global First Aid Kits MarketDue to the COVID19 pandemic the global First Aid Kits market size is estimated to be worth US 612.3 million in 2022 and is forecast to a readjusted size of US 934.5 million by 2028 with a CAGR of 7.3 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2E758
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Metformin Hydrochloride Market Insights and Forecast to 2028
Global Metformin Hydrochloride Market Insights and Forecast to 2028

While Metformin Hydrochloride Tablets segment is altered to an CAGR throughout this forecast period.Global Metformin Hydrochloride Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-1A9394
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Ginkgo Biloba Extract Market Insights and Forecast to 2028
Global Ginkgo Biloba Extract Market Insights and Forecast to 2028

The main active constituents include terpene lactones and flavone glycosides.Market Analysis and Insights Global Ginkgo Biloba Extract MarketDue to the COVID19 pandemic the global Ginkgo Biloba Extract market size is estimated to be worth US 197.2 million in 2022 and is forecast to a readjusted size of US 262.7 million by 2028 with a CAGR of 4.9 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30I398
Sun Jan 09 00:00:00 UTC 2022

Add to Cart